What a role map is not
A role map is orientation — not a job description, a competency framework, or a statement of what any employer expects of you.
You look after quality at a research site that runs studies for lots of different companies, each of which wants things done its own way.
You maintain the site’s own quality system and training records, host sponsor monitoring and audits alongside regulatory inspection, and reconcile each sponsor’s expectations with one set of site procedures.
The site is a provider, and its quality system is the asset that lets it take work from many sponsors at once. Every sponsor audit is both a scrutiny and a sales conversation.
YOUR NEIGHBOURHOOD, IN ONE CONNECTED SYSTEM
Inside the investigator site’s own quality function, facing every sponsor with a study running there.
PROVIDER SIDE · ONE SYSTEM, MANY CLIENTS
Working across clients
The eight facets above describe a role inside one organisation. Clinical Site Quality Lead is not in one, so these are the boundaries that replace a reporting line.
WHOSE SYSTEM GOVERNS
The site’s own quality system, which is what makes this the provider side rather than the client side. Each sponsor brings expectations that must be mapped onto it, and where a sponsor wants something the system does not do, the answer is a documented agreement rather than a second way of working for one study.
AUTHORITY
- How a sponsor’s expectation can be met within the site’s existing procedures
- Where a sponsor requirement conflicts with the site’s system or with another sponsor’s
- Any sponsor’s protocol, amendments or data decisions
- Which of two sponsors’ conflicting expectations prevails, without agreeing it with them
- Clinical decisions, which belong to the investigator
BETWEEN ENGAGEMENTS
- The site’s quality system and its inspection readiness, built across many sponsor audits
- Experience of what different sponsors ask for, as capability rather than as information
- One sponsor’s protocol, data or participants, into work for another
- What one sponsor’s audit found, into a conversation with a different sponsor
- Study records handed to each sponsor, which outlive the study
- The site’s retained records, which every future sponsor audit will read
- Allowing one sponsor’s records to be visible during another sponsor’s audit or facility tour
- Accepting a study whose requirements would breach a confidentiality obligation already owed
- Presenting the site’s compliance as the sponsor’s — the sponsor retains its own oversight duty
- A sponsor’s decision to place a study at the site
- Data leaving the site for any sponsor
- Every sponsor audit and regulatory inspection
- Investigators and coordinators following site procedures
- Training and delegation records being current
- Sponsors stating their expectations before the study starts, not during an audit
- Every sponsor with a study at the site
- The site’s own investigators and coordinators
- The site’s quality system and its state of control
- Training, delegation and qualification records
- The response to sponsor audits and to inspection
- Any sponsor’s protocol or its amendments
- A sponsor’s decisions about its data
- Medical decisions made by investigators
- The site’s leadership and the principal investigator
- The affected sponsor, promptly, for any event touching its study
- Site quality system records
- Training and delegation logs
- Audit and inspection responses
WHAT THIS ROLE CAN EVIDENCE · 0
No published competency maps to Clinical Site Quality Lead yet. 14 are published across the registry, and this role is not among the ones they name.
Read the standard and its stated coverage →A role map is Locate, moment 2 of 5: what surrounds your work, what you own, and what you escalate. It does not teach the practice or test it. Next is Learn — the Clinical Operations pathway. No scenario exercises this role yet, so Practise comes later for it, then what any of it evidences. Skip any of them — the order does not change.
The regulations and standards this pathway anchors on. SPEQ decodes and cites each one; the authoritative text lives at the official source.
- ICH E6(R3)Good Clinical Practice (GCP)ICH · last revised 2025-01-06
- ICH E8(R1)General Considerations for Clinical StudiesICH · last revised 2021-10-06
- 21 CFR Part 312Investigational New Drug Application (IND)FDA · last revised 2023-01-01
- 21 CFR Part 50Protection of Human Subjects (Informed Consent)FDA · last revised 2024-01-01